Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: Implicationsfor design of signal-specific PTH ligands
H. Takasu et al., Amino-terminal modifications of human parathyroid hormone (PTH) selectively alter phospholipase C signaling via the type 1 PTH receptor: Implicationsfor design of signal-specific PTH ligands, BIOCHEM, 38(41), 1999, pp. 13453-13460
Parathyroid hormone (PTH) and PTH-related peptide (PTHrP) activate the PTH/
PTHrP receptor to trigger parallel increases in adenylyl cyclase (AC) and p
hospholipase C (PLC). The amino (N)-terminal region of PTH-(1-34) is essent
ial for AC activation. Ligand domains required for activation of PLC, PKC,
and other effecters have been less well-defined, although some studies in r
odent systems have identified a core region [hPTH-(29-32)] involved in PKC
activation. To determine the critical ligand domain(s) for PLC activation,
a series of truncated hPTH-(1-34) analogues were assessed using LLC-PK1 cel
ls that stably express abundant transfected human or rat PTH/PTHrP receptor
s. Phospholipase C signaling and ligand-binding affinity were reduced by ca
rboxyl (C)-terminal truncation of hPTH-(1-34) but were coordinately restore
d when a binding-enhancing substitution (Glu(19) --> Arg(19)) was placed wi
thin hPTH-(1-28), the shortest hPTH peptide that could fully activate both
AC and PLC. Phospholipase C, but not AC, activity was reduced by substituti
ng Gly(1) for Ser(1) in hPTH-(1-34) and was eliminated entirely by removing
either residue 1 or the alpha-amino group alone. These changes did not alt
er binding affinity. These findings led to design of an analogue, [Gly(1),A
rg(19)]hPTH-(1-28), that was markedly signal-selective, with full AC but no
PLC activity. Thus, the extreme N-terminus of hPTH constitutes a critical
activation domain for coupling to PLC. The C-terminal region, especially hP
TH-(28-31), contributes to PLC activation through effects upon receptor bin
ding but is not required for full PLC activation. The N-terminal determinan
ts of AC and PLC activation in hPTH-(1-34) overlap but are not identical, a
s subtle modifications in this region may dissociate activation of these tw
o effecters. The [Gly(1),Arg(19)]hPTH-(1-28) analogue, in particular, shoul
d prove useful in dissociating AC- from PLC-dependent actions of PTH.